ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1–Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results
Heather A. Wakelee, Jyoti D. Patel, Rebecca Suk Heist et al. · Journal of Thoracic Oncology · 2016
Cited by 15 works. doi:10.1016/j.jtho.2016.09.009 Open-access PDF
Authors
- Heather A. Wakelee
- Jyoti D. Patel
- Rebecca Suk Heist
- Ani Sarkis Balmanoukian
- Benjamin Besse
- Enriqueta Felip
- Enric Carcereny
- Laura Q.M. Chow
- Marianna Koczywas
- Marina Chiara Garassino
- Daniel Christian Christoph
- Chee‐Keong Toh
- Melissa Lynne Johnson
- Jamie E. Chaft
- Takayasu Kurata
- Jiaheng Qiu
- Marcin Kowanetz
- Shelley Coleman
- Simonetta Mocci
- Alan Sandler